AstraZeneca

EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update

pr011
March
16
/ 2021

EMA is working closely with the company, with experts in blood disorders, and with other health authorities including the UK’s MHRA based on its experience with around 11 million administered doses of the vaccine.

Tags

Subscribe to AstraZeneca